Life Sciences Tools and Services
Company Overview of Second Genome, Inc.
Second Genome, Inc., a life sciences company, develops microbiome-modulating precision therapies. Its microbiome signature discovery services include solutions for microbiome analysis, such as biological specimen storage and sample preparation; sequencing (NGS) and array-based metagenomic assays; and bioinformatics pipelines. Second Genome, Inc. was formerly known as PhyloTech, Inc. and changed its name to Second Genome, Inc. in January 2011. The company was founded in 2009 and is based in San Bruno, California.
1150 Bayhill Drive
San Bruno, CA 94066
Founded in 2009
Key Executives for Second Genome, Inc.
Chief Executive Officer and President
Chairman of The Board and Co-Founder
Co-Founder and Chairperson of Scientific Advisory Board
Co-Founder and Head of Bioinformatics
Senior Vice President of Corporate Development
Compensation as of Fiscal Year 2014.
Second Genome, Inc. Key Developments
Second Genome, Inc. and Evotec AG to Collaborate in Microbiome Discovery and Development
Mar 13 15
Evotec AG and Second Genome, Inc. announced a collaboration in small molecule-based discovery and development activities for the treatment of microbiome-mediated diseases. The collaboration comprises the identification and optimisation of novel compounds as well as licence agreements for already existing assets developed by Evotec. Second Genome's unique approach to identify and modulate microbiome-mediated pathways will be further enhanced by the use and the results of Evotec's integrated drug discovery platform. As part of the collaboration, Second Genome and Evotec will work together to screen microbiome-mediated targets of interest identified by the Second Genome microbiome discovery platform with Evotec's technology platform, chemical libraries and other pre-clinical capabilities. The agreement between Evotec and Second Genome triggers an undisclosed upfront payment. Evotec is also eligible for pre-clinical, clinical and regulatory milestones as well as royalty payments related to commercialisation.
Second Genome, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:10 PM
Feb 26 15
Second Genome, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:10 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States.
Second Genome, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-10-2015 08:00 AM
Jan 20 15
Second Genome, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-10-2015 08:00 AM. Venue: The Waldorf Astoria, New York, New York, United States. Speakers: Karim Dabbagh, Chief Scientific Officer.
Similar Private Companies By Industry
Recent Private Companies Transactions
October 7, 2014